Bill Title: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols

Sponsorship: Partisan Bill (Democrat 1)

Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]

Text: Latest bill text (Chaptered) [PDF]

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2023 Louisiana HB403 at this time.